相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma
Phung Nguyen et al.
LIFE SCIENCES (2022)
Why 90 % of clinical drug development fails and how to improve it?
Duxin Sun et al.
ACTA PHARMACEUTICA SINICA B (2022)
Chalcogen and Hydrogen Bonds at the Periphery of Arylhydrazone Metal Complexes
Atash Gurbanov et al.
CRYSTAL GROWTH & DESIGN (2022)
Transcriptomic analysis of glioblastoma multiforme providing new insights into GPR17 signaling communication
Gnanavel Mutharasu et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
TheAutoDocksuite at 30
David S. Goodsell et al.
PROTEIN SCIENCE (2021)
Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment
Phung Nguyen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent
Mohammad Rashid
BIOORGANIC CHEMISTRY (2020)
Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol through the Modulation of EGFR and CSC Signaling Pathways
Phuong Doan et al.
CELLS (2020)
Resonance Assisted Chalcogen Bonding as a New Synthon in the Design of Dyes
Atash Gurbanov et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
T Cell Activation Depends on Extracellular Alanine
Noga Ron-Harel et al.
CELL REPORTS (2019)
2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma
Anisha Viswanathan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Identification of novel GPR17-agonists by structural bioinformatics and signaling activation
Konda Mani Saravanan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
Alyssa M. Vanderbeek et al.
NEURO-ONCOLOGY (2018)
In vitro characterization of arylhydrazones of active methylene derivatives
Suresh Palanivel et al.
SAUDI PHARMACEUTICAL JOURNAL (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors
Mansour S. Alsaid et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
DNA and BSA binding and cytotoxic properties of copper(II) and iron(III) complexes with arylhydrazone of ethyl 2-cyanoacetate or formazan ligands
Nuno M. R. Martins et al.
NEW JOURNAL OF CHEMISTRY (2017)
DNA and BSA binding, anticancer and antimicrobial properties of Co(II), Co(II/III), Cu(II) and Ag(I) complexes of arylhydrazones of barbituric acid
Jessica Palmucci et al.
RSC ADVANCES (2016)
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activation
Debbie L. Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Di- and tri-organotin(IV) complexes of arylhydrazones of methylene active compounds and their antiproliferative activity
Kamran T. Mahmudov et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2014)
A review exploring biological activities of hydrazones
Garima Verma et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2014)
P75 neurotrophin receptor is sequestered in the Golgi apparatus of the U-87 MG human glioblastoma cell line
Stephanie Giraud et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Synthesis and biological evaluation of novel 2,4′-bis substituted diphenylamines as anticancer agents and potential epidermal growth factor receptor tyrosine kinase inhibitors
Sahar Mahmoud Abou-Seri
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
p62 serves as a shuttling factor for TrkA interaction with the proteasome
Thangiah Geetha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
4-amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors
Guozhang Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Jayne M. Stommel et al.
SCIENCE (2007)
Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways
S Descamps et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)